Nearly two decades ago, a groundbreaking discovery in the field of biomedical research emerged, known as organ-on-a-chip technology, which quickly captivated the interest of scientists across the globe. Led by …
I always think of the Jeff Goldblum quote in Jurassic Park where he says "life finds a way" when I think of cancer. However, I simply substitute the word life …
We are witnessing a revolution in cancer therapeutics that is truly bewildering. The number of novel drugs with unique mechanisms of action currently in clinical trial and development is staggering, …
In the incredibly competitive world of drug development, comprehensive precision, and healthtech, every strategic control point is essential. Over the next several months, during this editorial series, we will admittedly …
In 1945 the volume of human knowledge doubled every 25 years. Now, that number is 12 hours [1]. With our collective computational power rapidly increasing, vast amounts of data and …
Chapter 1 of a 3-chapter Hitchhiker’s guide to cell-free DNA for travelers of all backgrounds and expertise. Even though I’ve been a hematologist/oncologist for over a decade, I’m horrendous at …
Chapter 2 of a Hitchhiker's Guide to Cell-Free DNA. By the end of 2022, there will be an estimated 609,360 deaths cause by cancer in the US alone [1]. In …
Advances in computational biology, precision medicine, artificial intelligence/machine learning, etc., are launching us into a world where strategic control points in drug discovery, pharmaceuticals, clinical trials, etc., will never be …
Healthcare is one of the cornerstones of our society. High-quality healthcare is effective, patient-centric and vital for the population's well-being. However, healthcare alone accounts for 5% of global greenhouse gas …
Researchers at the Massachusetts Institute of Technology (MIT) have made significant advancement in the study of cellular processes such as cancer progression and embryonic development. This innovative method utilizes Raman spectroscopy, …
In a notable advancement for the fast-moving consumer goods (FMCG) industry, Spore.Bio, a deeptech startup, has recently raised €8 million in a pre-seed funding round. This funding was led by LocalGlobe and will …
The clinical trial is a critical stage of drug development workflow, with an estimated average success rate of about 11% for drug candidates moving from Phase 1 towards approval. Even …
We use cookies to personalise content and to analyse our traffic.
You consent to our cookies if you continue to use our website. Read more details in our
cookies policy.